ZELTIQ Aesthetics (ZLTQ) : The highest level ZELTIQ Aesthetics (ZLTQ) is projected to reach is $48 for the short term and the lowest estimate is at $38. The consolidated price target from 7 rating analysts who initiate coverage on the stock is $43.43 and the possibility the share price can swing is $4.47.
ZELTIQ Aesthetics (ZLTQ) : 8 brokerage houses believe that ZELTIQ Aesthetics (ZLTQ) is a Strong Buy at current levels. Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 8 Wall Street Analysts endorse the stock as a Strong Buy with a rating of 1.
Also, Major Brokerage house, JP Morgan maintains its ratings on ZELTIQ Aesthetics (NASDAQ:ZLTQ). In the latest research report, JP Morgan raises the target price from $27 per share to $35 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on August 9, 2016.
ZELTIQ Aesthetics (NASDAQ:ZLTQ): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $38.00 and $37.59 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $38.33. The buying momentum continued till the end and the stock did not give up its gains. It closed at $38.21, notching a gain of 0.24% for the day. The total traded volume was 350,834 . The stock had closed at $38.12 on the previous day.
ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.